Properties (61)
Predicate | Object |
---|---|
gptkbp:instanceOf |
biotechnology company
|
gptkbp:acquisition |
TIL_technology_from_the_National_Cancer_Institute
|
gptkbp:advertising |
focused on cell therapies
|
gptkbp:budget |
published
|
gptkbp:businessModel |
cell therapy development
|
gptkbp:CEO |
Maria_Fardis
|
gptkbp:clinicalTrials |
ongoing
Phase 2 Phase 3 publicly traded multiple stages multiple sites published in journals analyzed regularly tumor-infiltrating lymphocyte therapy |
gptkbp:collaborations |
academic institutions
biopharmaceutical companies ongoing with universities |
gptkbp:community_engagement |
active
|
gptkbp:community_service |
engaged with
defined for trials |
gptkbp:conference |
participates in
|
gptkbp:employeeCount |
growing
|
gptkbp:enrollment |
targeted for therapies
|
gptkbp:financialPerformance |
monitored
publicly reported |
gptkbp:financials |
conducted regularly
|
gptkbp:focus |
cell therapy
|
gptkbp:founded |
2014
|
gptkbp:funding |
secured from investors
|
gptkbp:future_plans |
expansion of pipeline
|
gptkbp:headquarters |
gptkb:San_Carlos,_California
|
https://www.w3.org/2000/01/rdf-schema#label |
Iovance Biotherapeutics
|
gptkbp:industry |
operating in
|
gptkbp:investmentFocus |
active
various venture capital firms |
gptkbp:is_aimed_at |
gptkb:melanoma
cervical cancer non-small cell lung cancer head and neck cancer |
gptkbp:market |
varies
oncology |
gptkbp:partnerships |
various pharmaceutical companies
various organizations |
gptkbp:patentCitation |
filed_for_TIL_technology
|
gptkbp:patentType |
pending_for_Lifileucel
|
gptkbp:products |
Lifileucel
|
gptkbp:publications |
numerous
|
gptkbp:regulatoryCompliance |
ongoing
investigational |
gptkbp:research |
focused on TILs
|
gptkbp:research_areas |
cancer
|
gptkbp:research_focus |
immunotherapy
|
gptkbp:sells |
gptkb:NASDAQ
|
gptkbp:stockSymbol |
gptkb:IOVA
|
gptkbp:supplyChain |
Lifileucel
|
gptkbp:supportRole |
established
|
gptkbp:team |
experienced professionals
|
gptkbp:tributaryOf |
multiple candidates
|
gptkbp:updates |
provided regularly
|
gptkbp:website |
www.iovance.com
|